• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

LifeCare Chiropractic

The Best Chiropractic Care in Mesa, Arizona

  • Home
  • About
    • Why Lifecare?
    • About Dr. Bogash
    • Team Members
  • Common Conditions
    • Wrist Pain/Carpal tunnel syndrome
    • Elbow Pain/Epicondylitis
    • Headaches
    • Knee Pain and Knee Injuries
    • Low Back Pain
    • Shoulder Pain and Rotator Cuff Problems
  • Additional Services
  • Testimonials
  • Blog
  • E-Books
  • Contact

LDL

PREDICTION OF CORONARY HEART DISEASE IN MEN – (12-19-05)

May 25, 2012 by James Bogash

non-HDL cholesterol High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men

ApoB is the protein component of a lipid molecule that carries around the cholesterol. This study compared which was a better marker for coronary heart disease–non HDL cholesterol (the amount of LDL and VLDL cholesterol together) vs ApoB. Elevated ApoB was the best predictor of risk at 4.18 times the risk. Above and beyond “traditional” risk factors.

This is not the first study to come to this conclusion, and yet it’s use is still few and far between in clinical practice.

Read entire article here

Filed Under: Cholesterol, Heart Disease Tagged With: ApoB, cholesterol, Coronary Heart Disease, LDL, VLDL

JUST CHECKING CHOLESTEROL DOES NOT GIVE A GOOD PICTURE OF HEART DISEASE – (02-21-05)

May 13, 2012 by James Bogash

Insulin resistance, adiposity influence lipoprotein size, subclass concentrations

This study really demonstrates how behind the research most clinicians are.  Just checking cholesterol really does not give us a good picture of where the patient is as far as their risk for heart disease.

This study evaluated subclasses of LDL (small, intermediate, large), VLDL (very low density lipoprotein) and HDL.  Worsening insulin resistance did not affect LDL levels.  However, strong changes were seen in the subclasses–decrease in the large LDL offset increases in the other sizes of LDL.

So, if one just looks at straight LDL, you just missed the fact that the real picture is one of worsening risk (larger LDL and larger HDL particles are generally considered protective).  Subfractioning of the cholesterol molecules is looking more and more like a good idea…

Read entire article here

Filed Under: Cholesterol, Heart Disease Tagged With: cholesterol, HDL, heart disease, insulin resistance, LDL, Lipoprotein, VLDL

RISKS OF CHOLESTEROL IN CORONARY HEART DISEASE – (04-30-07)

April 5, 2012 by James Bogash

Non–High-Density Lipoprotein and Very-Low-Density Lipoprotein Cholesterol and their Risk Predictive Values in Coronary Heart Disease

Invariably, when I give a presentation to a group in the community, maybe 1 out of 20 know their lipids outside of total cholesterol. The reality is, you absolutely, positively CANNOT appropriately manage elevated lipids without knowing where your HDL, VLDL and triglycerides are. And yet PCP and Internists still look at lipids with blinders on and will aggressively treat patients based on total cholesterol alone.

And yet here, researchers found NO association between elevated LDL and CVD risk. Good thing the only bad thing that happens from statin drug use is fatal rhabdomyolysis.

Read entire article here

Filed Under: Cholesterol, Heart Disease Tagged With: cholesterol, Coronary Heart Disease, CVD, HDL, LDL, Lipoprotein, triglycerides, VLDL

WHAT’S THE AVERAGE PRIMARY CARE DOCS GIVE TO CHOLESTEROL PATIENTS? – (03-05-07)

April 5, 2012 by James Bogash

A Population-Based, Cross-Sectional Comparison of Lipid-Related Indexes for Symptoms of Atherosclerotic Disease

“In conclusion, these observations add to the published data suggesting that LDL cholesterol may not be the best target of lipid-lowering treatment strategies.” Wow. What’s the average primary care doc going to do? We’ve become so blinded to checking LDL and total cholesterol that we haven’t seemed to notice that other markers do a much better job of predicting heart disease then cholesterol.

I can honestly tell you that I’ve had patients come in being aggressively put on statins for a cholesterol level under 230 that would’ve responded to something as simple as a handul of almonds.

Read entire article here

Filed Under: Cholesterol, Heart Disease Tagged With: Atherosclerotic Disease, cholesterol, heart disease, LDL, statins

HOW WELL ARE WE MANAGING HEART DISEASE RISK FACTORS?

May 25, 2011 by James Bogash

Let’s face it.  If you are willing to make changes, managing cardiac risk factors is a piece of cake (or rather…avoiding that piece of cake…).  Lifestyle changes are not difficult, but require commitment.  Society does not easily support healthy lifestyle and requires a shift from what you’ve been doing.  But the payoffs are massive for you and your family.

I continue to contend that lifestyle changes are the ONLY way to manage chronic diseases.  Maybe if we did not live under the false pretense that, because our “numbers” look better (cholesterol, HbA1c, blood pressure, blood glucose, etc…), we’ve dodged the bullet of early death.  I cannot stress enough that this is just not true.  We live in a society dominated by surrogate end markers.  We think that because our cholesterol has magically been lowered by the coveted, mystical statin that we’ve lowered our risk for a heart attack or stroke.  Ok–so maybe you have, but only by a SMIDGEN (which, in medical terminology, is about 1%).  This is NOT prevention, it is false hope.  Lifestyle changes, on the other hand, have true global health benefits that are unquestionable.

This particular study just reinforces how pathetic “we” are when it comes to cardiac risk factors.  We can’t even do it right using drugs!  In shooting for lower LDL levels AND optimal CRP levels (a marker of inflammation) only 12% of the patients in this large study managed to achieve the desired numbers.  You will hopefully note that they were looking at LDL levels and not total cholesterol.  Hopefully, we are finally abandoning the futility of checking total cholesterol in lieu of better markers.

The authors’ suggestions?  “Smoking cessation, weight reduction, and the greater use of more potent statins at higher doses might be able to improve these outcomes.”  We just don’t get it.  It’s almost laughable how sickeningly dependent we have become on medication to “protect” our health.  Even with a society heavily dependent on meds, we still can’t get 88% of the population to target levels.

http://www.sciencedirect.com/science/article/pii/S0002914911004632

Filed Under: Cholesterol, Heart Disease, Inflammation Tagged With: CRP, heart disease, LDL, lifestyle changes, statins

  • « Go to Previous Page
  • Page 1
  • Page 2

Primary Sidebar

Patient Quick Guide

Schedule An Appointment
Contact Our Office
Download Patient Forms

Categories

Chiropractic Mesa Arizona

Arthritis Chiropractor Mesa AZ
Graston Technique Mesa AZ
Back Pain Chiropractor Mesa AZ
Back Pain Doctor Mesa AZ
Wrist Pain Chiropractor Mesa AZ
Rotator Cuff Chiropractor Mesa AZ
Shoulder Pain Chiropractor Mesa AZ
Knee Pain chiropractor Mesa AZ
Manipulation Under Anesthesia In Mesa AZ
Headache Chiropractor Mesa AZ
Chiropractic Mesa AZ
Stem Cell Therapy Mesa AZ
Regenerative Medicine Mesa AZ
Massage Therapist Mesa AZ
Shoulder Pain Doctor Mesa AZ
PRP Therapy Mesa AZ
Chiropractic Mesa AZ
Who Is The Top Chiropractor In Mesa AZ?
Knee Injury Doctor Mesa AZ?

Footer

Resources

Site Map
Disclosure
Additional Resources

Best Massage Therapist Mesa AZ
Arthritis Doctor Mesa AZ
Chiropractic Mesa AZ
Back Pain Doctor Mesa AZ
Rotator Cuff Doctor Mesa AZ
Chiropractor Mesa AZ
Massage Therapist Mesa AZ
PRP Therapy Mesa AZ
Knee Pain Doctor Mesa AZ
Stem Cell Therapy Mesa AZ
Headache Doctor Mesa AZ
Shoulder Pain Doctor Mesa AZ

Office

Lifecare Chiropractic
1830 S. Alma School Rd, Ste 135
Mesa, AZ 85210
(480)-839-2273
Also Serving Tempe, AZ

Get Directions

  • Home
  • About
  • Common Conditions
  • Additional Services
  • Testimonials
  • Blog
  • E-Books
  • Contact

Copyright © 2026 · LifeCare Chiropractic · All Rights Reserved.